Thérapie de la myopathie de Duchenne de Boulogne - DUMAS
Pancreatic Cancer (LAPC). Metastatic Pancreatic Cancer. 1H 2024. TBD. Duchenne ... ? Pamrevlumab can potentially be used in a broad range of DMD patients ...
An Update on Gemcitabine-Based Chemosensitization Strategies in ...Pancreatic ductal adenocarcinoma (PDAC) is characterized by abundant stroma, the main cellular constituents of which are cancer-associated fibroblasts (CAFs). TITLE PAGE - ClinicalTrials.govIn a phase I study, the safety and efficacy of increasing doses of pamrevlumab were evaluated in combination with two chemotherapy agents, ... Pancreatic Cancer A ReviewHere we review the role of the individual growth factors in pancreatic cancer chemoresistance. Importantly, the interplay between the tumor ...
Autres Cours:
